Drug Shortage Report for FLULAVAL TETRA

Last updated on 2018-03-31 History
Report ID 24222
Drug Identification Number 02420783
Brand name FLULAVAL TETRA
Common or Proper name Quadrivalent Influenza Vaccine (Split Virion, Inactivated)
Company Name ID BIOMEDICAL CORPORATION OF QUEBEC
Market Status MARKETED
Active Ingredient(s) HAEMAGGLUTININ-STRAIN B HAEMAGGLUTININ-STRAIN B HAEMAGGLUTININ-STRAIN A HAEMAGGLUTININ-STRAIN A
Strength(s) 15MCG 15MCG 15MCG 15MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1 vial X 10 doses
ATC code J07BB
ATC description VIRAL VACCINES
Reason for shortage Other (Please describe in comments)
Anticipated start date 2017-09-27
Actual start date 2017-09-27
Estimated end date 2018-03-30
Actual end date 2018-03-30
Shortage status Resolved
Updated date 2018-03-31
Company comments 2017-2018 flu vaccine production less that anticipated. Supply disruption in the private market. Doses reserved for public vaccination programs.
Health Canada comments
Tier 3 Status No
Company contact information GlaxoSmithKline Customer Service: 1 800 387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2018-03-31 English Compare
v9 2017-10-03 French Compare
v8 2017-10-03 English Compare
v7 2017-10-03 French Compare
v6 2017-10-03 English Compare
v5 2017-10-03 English Compare
v4 2017-10-03 English Compare
v3 2017-10-03 French Compare
v2 2017-10-03 English Compare
v1 2017-10-03 English Compare

Showing 1 to 10 of 10